Press release
Oncolytic Virus Therapies market size was approximately USD 122 million in 2021
The Oncolytic Virus Therapies market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM pancreatic cancer market size. The report also covers current Oncolytic Virus Therapies treatment practice, SWOT analysis, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Key takeaways from the Oncolytic Virus Therapies Market Research Report
• In 2021, the total Oncolytic Virus Therapies market size was approximately USD 122 million which is expected to rise during the study period (2019-2032).
• In 2021, the total Oncolytic Virus Therapies target patient pool cases across 7MM were about 632 K which are expected to grow during the study period, i.e., 2019-2032.
• Oncolytic Virus Therapies Companies are working such as Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen, Daiichio Sankyo, and others.
• Oncolytic Virus Therapies Pipeline therapies such as ADV/HSV-tk, Valacyclovir, SBRT, Pembrolizumab, TBI-1401(HF10), Gemcitabine, TS-1, CG0070, GL-ONC1, MEDI5395, and others.
Discover more about therapies set to grab major Oncolytic Virus Therapies Market Size @ https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Oncolytic Virus Therapies Overview
Oncolytic viruses considered an effective anticancer strategy in recent years are a special type of virus that are naturally or genetically engineered and can replicate preferentially in tumor cells and inhibit tumor growth. Oncolytic Virus Therapy is a treatment using a virus that can replicate itself to kill cancer cells. Many species of viruses exist, but not all can be designed to be oncolytic viruses (OV). The typical features of these OVs must include being non-pathogenic, the ability to target and kill the cancer cells, and the capacity to be transformed to express tumor-killing factors through genetic engineering methods.
Oncolytic Virus Therapies Epidemiology Segmentation in the 7MM
• Total Oncolytic Virus Therapies Incident Cases of selected cancer types
• Oncolytic Virus Therapies Target Patient Pool by Cancer Types
• Oncolytic Virus Therapies Treated Cases by Cancer Types
Download the report to understand which factors are driving Oncolytic Virus Therapies Market Outlook @ https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Oncolytic Virus Therapies Treatment Market
The currently available treatment options for cancers include immunotherapy, radiotherapy, chemotherapy, targeted drug therapy, hormone therapy and others. However not all patients are able to get benefit from these therapies, as patients develop resistance against these therapies. The present immunotherapy paradigm's major flaw is its emphasis on adaptive immunity at the expense of immunity. While some of these hurdles can be addressed by combination systemic treatments such as dual checkpoint inhibition, the side effects of such multidrug regimens can be significant. To combat such a scenario, Oncolytic Virus Cancer Therapy seems to be the tempting and best approach by Showing dual mechanism of action: Direct oncolysis and immune-mediated anticancer effect and Overcoming resistance by alternative cell killing mechanism.
Oncolytic Virus Therapies Market Insights
Oncolytic Virus Cancer Therapy Market Size is estimated to grow. According to the estimates, the highest market size of Oncolytic Virus Cancer Therapy will be contributed from the United States. It is important to mention that, Imlygic's debut did not translate into much commercial success in the melanoma market. Limitations of the Oncolytic Virus Cancer Therapy, no statistically significant benefit in overall survival and the intense competition from immune checkpoint inhibitors due to their efficacy and manageable side effects are some of the main factors for insignificant revenues of this novel therapy.
Read more for Oncolytic Virus Therapies treatment options @ https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Oncolytic Virus Therapies Market Research Report
• Coverage- 7MM
• Study Period- 2019-2032
• Forecast Period- 2022-2032
• Oncolytic Virus Cancer Therapy Companies- Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen, Daiichio Sankyo, and others
• Oncolytic Virus Therapies Pipeline therapies such as ADV/HSV-tk, Valacyclovir, SBRT, Pembrolizumab, TBI-1401(HF10), Gemcitabine, TS-1, CG0070, GL-ONC1, MEDI5395, and others.
• Oncolytic Virus Cancer Therapy Market Access and Reimbursement
• KOL Views, SWOT Analysis, Unmet Needs
Table of Content
1. Key Insights
2. Report Introduction
3. Oncolytic Virus Therapies Market Overview at a Glance
4. Key Highlights from Oncolytic Virus Therapies Report
5. Executive Summary of Oncolytic Virus Therapies
6. Epidemiology and Market Forecast Flow
7. Background and Overview
8. Oncolytic Virus Therapies Epidemiology and Patient Population
9. Key Endpoints in OVTs
10. Oncolytic virus therapies Marketed therapies
11. Oncolytic virus therapies Emerging Therapies
12. Attribute Analysis
13. Oncolytic virus therapies: 7 Major Market Analysis
14. Market Access and Reimbursement
15. Oncolytic virus therapies KOL Views
16. Oncolytic virus therapies SWOT Analysis
17. Oncolytic virus therapies Unmet Needs
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Do you have any queries? Connect with our Business Expert @ https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Therapies market size was approximately USD 122 million in 2021 here
News-ID: 2814090 • Views: …
More Releases from DelveInsight Business Research
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis…
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast
https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Oncolytic
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth?
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering…
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer.
Download Report:
https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas
The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take…
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy.
New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate…
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Oncolytic Virus Competitive Landscape Report
• DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
